Invesaro

Stocks Health care SCLX

NASDAQ · Health care

Scilex Holding Co (SCLX)

Scilex Holding Co brought in $31.6M of revenue over the twelve months to June 30, 2026, down 28.5% from a year earlier. It posted a net loss of $464.6M. Operating cash flow minus capital spending left $3.7M of free cash flow in fiscal 2025. At June 30, 2026 it held $566K in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 14, 2026.

Price
$4.89
-1.01% on the day · September 25, 2026
52-week range $2.62 to $18.58
Market cap
$41.5M
Revenue (last 12 months)
$31.6M
-28.5% year on year
Net margin
-1,469.8%

What Scilex Holding Co does

Scilex Holding Co is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker SCLX.

Revenue and profit by year

Revenue
FY20: $23.6M $23.6M FY20FY21: $31.3M $31.3M FY21FY22: $38M $38M FY22FY23: $46.7M $46.7M FY23FY24: $56.6M $56.6M FY24FY25: $30.3M $30.3M FY25
Net income
FY20: -$47.5M -$47.5M FY20FY21: -$88.4M -$88.4M FY21FY22: -$23.4M -$23.4M FY22FY23: -$114.3M -$114.3M FY23FY24: -$72.8M -$72.8M FY24FY25: -$374.1M -$374.1M FY25

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Fiscal yearRevenueOperating incomeNet incomeDiluted EPSFree cash flow
2025$30.3M-$346M-$374.1M-$36.48$3.7M
2024$56.6M-$83.4M-$72.8M-$8.05$19.3M
2023$46.7M-$105.4M-$114.3M-$16.89-$20.7M
2022$38M-$50.6M-$23.4M-$2.24-$21.3M
2021$31.3M-$35.8M-$88.4M-$8.84-$28.7M
2020$23.6M-$35.3M-$47.5M-$4.75-$31.5M

Latest SEC filings

What Scilex Holding Co has filed recently, newest first. Each links to the original document on SEC EDGAR.

  1. August 14, 2026
    Quarterly report 10-Q · period to June 30, 2026
  2. August 12, 2026
  3. July 22, 2026
  4. July 7, 2026
  5. July 6, 2026
  6. June 30, 2026
  7. June 29, 2026
  8. June 26, 2026
  9. June 24, 2026
  10. June 2, 2026

Recent insider filings (Forms 3, 4 and 144): 9, the latest on July 7, 2026. Insider transactions on SEC

All filings on SEC EDGAR

Questions about SCLX

What does Scilex Holding Co do?

Scilex Holding Co is registered with the SEC under industry code SIC 2836 (Biological Products, (No Diagnostic Substances)). Its shares trade on NASDAQ under the ticker SCLX.

Is Scilex Holding Co profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $464.6M on revenue of $31.6M.

How much revenue does Scilex Holding Co make?

Over the twelve months to June 30, 2026 Scilex Holding Co reported revenue of $31.6M. That is 28.5% less than a year earlier.

When did Scilex Holding Co last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 14, 2026. It covers the period to June 30, 2026.

Similar companies

Follow SCLX

Get an email when Scilex Holding Co files with the SEC: results, executive changes, material agreements and annual reports.

Follow SCLX: get an email when it files

Where the numbers come from

Financial figures are the values Scilex Holding Co tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.